Who Owns IQVIA Company?

IQVIA Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who Owns IQVIA?

Understanding a company's ownership is key to grasping its direction and influence. The 2016 merger of Quintiles and IMS Health formed IQVIA, a major player in health information and clinical research.

This union created a global leader, blending data insights with clinical expertise to advance healthcare worldwide. The company's structure reflects this integrated approach.

IQVIA, established in 2016, merged IMS Health and Quintiles. The name IQVIA reflects its heritage: 'I' for IMS Health, 'Q' for Quintiles, and 'VIA' meaning 'by way of.' The company's mission is to power smarter healthcare globally, leveraging data and clinical research.

As of 2024, IQVIA reported a revenue of US$15.4 billion. The company is a leading contract research organization (CRO). Examining its ownership reveals the influence of founders, institutional investors, private equity, and public shareholders, highlighting significant shifts over time. For a deeper look at its market position, consider an IQVIA Porter's Five Forces Analysis.

The foundation of IQVIA is built upon the distinct origins of two key companies: IMS Health and Quintiles. These entities, each with their own entrepreneurial beginnings, eventually merged to form the organization known today.

IMS Health Origins IMS Health, originally Intercontinental Marketing Services, was founded in 1954 by Bill Frohlich and David Dubow. They aimed to provide essential pharmaceutical sales data and market intelligence, filling a significant industry void. Public Offering of IMS Health In 1972, IMS Health transitioned to a publicly owned company. It was listed on the New York Stock Exchange under the ticker symbol RX, marking its entry into the public markets. Quintiles Founding Quintiles was established in North Carolina in 1982 by Dennis Gillings, a biostatistics professor. His initial work involved providing statistical and data management consulting to pharmaceutical clients. Gillings' Early Stake By April 2003, founder Dennis Gillings held a significant ownership stake in Quintiles, owning approximately 5.5% of the company's shares. This demonstrates his substantial early investment. Quintiles' Private Acquisition In 2003, Quintiles became a private entity again following an acquisition valued at $1.75 billion. This transaction involved Gillings and One Equity. Quintiles' Re-Public Offering Quintiles later returned to the public market in 2013. The company began trading on the NYSE under the ticker symbol Q, re-establishing its presence as a publicly traded entity.

The early ownership structures of both IMS Health and Quintiles were characterized by the vision of their founders and their initial strategic decisions regarding public and private operations. These distinct paths eventually converged, shaping the current ownership landscape.

Key Early Ownership Aspects

Understanding the initial ownership of IMS Health and Quintiles is crucial for grasping the company's evolution. These early stages laid the groundwork for future developments and the eventual formation of IQVIA.

• IMS Health was founded in 1954 by Bill Frohlich and David Dubow.
• IMS Health became a public company in 1972, trading as RX on the NYSE.
• Quintiles was founded in 1982 by Dennis Gillings.
• Dennis Gillings held approximately 5.5% of Quintiles' shares in 2003.
• Quintiles was taken private in 2003 and then went public again in 2013 as Q.
• The separate histories of IMS Health and Quintiles are fundamental to understanding Competitors Landscape of IQVIA and its overall ownership structure.

IQVIA SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The most significant event shaping IQVIA's ownership was the 2016 merger of Quintiles and IMS Health. This $9 billion transaction led to IMS Health shareholders holding 51.4% of the combined entity, initially named QuintilesIMS, which was later rebranded as IQVIA in November 2017.

As a publicly traded company on the NYSE under the ticker IQV, IQVIA's ownership is predominantly held by institutional investors. As of March 31, 2025, these institutions collectively own approximately 92.35% of the company's outstanding shares. This significant institutional backing can substantially influence the company's strategic direction and stock performance, impacting the Target Market of IQVIA.

IQVIA's Major Shareholders

Institutional investors are the primary owners of IQVIA stock. Their holdings can significantly impact the company's trajectory.

• Vanguard Group Inc. held 11.47% as of March 2025.
• BlackRock, Inc. owned 8.54% as of March 2025.
• Harris Associates L.P. had a stake of 6.46% as of March 2025.
• State Street Global Advisors, Inc. held 4.46% as of March 2025.
• Canada Pension Plan Investment Board owned 2.66% as of March 2025.
• Geode Capital Management, LLC held 2.45% as of March 2025.

IQVIA PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The Board of Directors at IQVIA is instrumental in guiding the company's strategic direction and corporate governance. Key individuals like Ari Bousbib, serving as Chairman & CEO, and John M. Leonard, the Lead Director, are central to the board's operations. Several directors, including John G. Danhakl and Todd B. Sisitsky, bring prior experience from legacy companies, reflecting the company's merger history.

IQVIA's voting structure is based on a one-share-one-vote principle for its common stock, as outlined in its Certificate of Incorporation. This means each share of common stock grants its holder a single vote on matters presented to stockholders. While the board has the authority to issue preferred stock with different voting rights, the current framework for common stock ensures a straightforward voting power distribution among IQVIA shareholders. This structure is fundamental to understanding IQVIA ownership and how decisions are made.

Enhanced Corporate Governance at IQVIA

IQVIA has recently strengthened its corporate governance framework to enhance shareholder influence and transparency. These updates aim to align the company's practices with modern governance standards, impacting how IQVIA stock ownership translates into decision-making power.

• The Board of Directors is now fully declassified, with all directors elected annually.
• A majority voting standard is applied in uncontested director elections.
• A resignation policy is in place for directors who do not receive majority support.
• Supermajority vote requirements for stockholder actions have been eliminated.
• Stockholders now have the right to request special meetings.

These governance enhancements are crucial for investors seeking to understand IQVIA company ownership structure explained and how their voting power might be exercised. The move towards annual elections and majority voting standards signifies a commitment to greater accountability to IQVIA shareholders. For those interested in the strategic direction and Growth Strategy of IQVIA, these governance changes are important considerations.

IQVIA Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Recent developments show a strong focus on returning value to IQVIA shareholders, with significant share repurchases and a growing institutional ownership stake. These trends highlight investor confidence in the company's strategic direction and its expanding technology and analytics capabilities.

Institutional investors now hold a substantial majority of IQVIA's shares, indicating a significant concentration of ownership among large financial entities. This increased institutional ownership, reaching approximately 92.35% as of March 2025, reflects a strong belief in the company's growth trajectory, particularly its investments in AI and strategic partnerships.

Major Institutional Holders

Key IQVIA shareholders include Vanguard Group Inc., BlackRock, Inc., and State Street Corp. These entities collectively manage vast portfolios, demonstrating significant influence over the company's direction.

Strategic Growth Focus

IQVIA's strategy involves leveraging AI-driven solutions and expanding its technology offerings. Collaborations, such as the one with NVIDIA for advanced AI, are central to this expansion.

Financial Outlook

The company has updated its 2025 revenue guidance to be between $16.1 billion and $16.3 billion. This revised forecast underscores confidence in the sustained demand for its AI-powered services.

Shareholder Value Initiatives

IQVIA's commitment to shareholder returns is evident through its ongoing share repurchase programs. These buybacks aim to enhance shareholder value and reflect a positive outlook on the company's performance, as detailed in its Brief History of IQVIA.

IQVIA Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔